Começar
Axsome Therapeutics, Inc.

$AXSM on POSSIBLE PLUMMETS

Por moannana
AXSM clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system, it is accelerating the completion of the ADVANCE-1 Phase 2/3 trial of AXS-05 in patients with Alzheimer’s disease agitation to ensure the safety of this vulnerable patient population during the COVID-19 pandemic. i expect that this end of the month its increasing thoroughly. Are you guys ready to get through resistance? why not?
AXSMBeyond Technical AnalysisdijTechnical IndicatorsNasdaq Composite Index CFDSPX (S&P 500 Index)Trend AnalysisVIX CBOE Volatility Index
moannana

Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.